Technavio has been monitoring the vitamin C supplements market and it is poised to witness a decremental growth of USD 2.52 billion during 2020-2024. This press release features multimedia. Technavio suggests three forecast scenarios considering the impact of COVID-19.
Infiniti Research is the world's leading independent provider of strategic market intelligence solutions. This press release features multimedia. Engagement Overview: Our client, a pharmaceutical company, wanted to expand their operations to the United States. Other key objectives of the client were: Objective 1: Gather insights for the R&D team.
Paul Fioravanti is Managing Partner of Qadent Management Services, LLC, a Florida based turnaround, restructuring, performance improvement firm and is an expert on transforming businesses facing extreme difficulty.
Rob Gronkowski returns to professional football with CBDMEDIC playing a key role in his recovery and comeback. Abacus Health Products, Inc. (ABAHF) today announces its support of Rob Gronkowskis, three-time professional football champion, decision to return to play professional football. This press release features multimedia.
Magellan Rx Management, a division of Magellan Health, Inc. (MGLN), released its tenth annual Medical Pharmacy Trend Report, featuring a comprehensive view of medical benefit drug trendsone of the largest drivers of total specialty drug spend.
SpendEdge has been monitoring the global drug intermediates and APIs market and the market is poised to experience spend growth of more than USD 80 billion between 2019-2024 at a CAGR of over 6% during the forecast period. This press release features multimedia.
Takeda Pharmaceutical Company Limited (TAK) today announced the completion of its previously-announced sale of a portfolio of select over-the-counter and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of $200 million USD.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
